06/03/2020

CEPI awards up to US$14.1million to consortium of IVI and Bharat Biotech to advance development of Chikungunya vaccine in collaboration with Ind-CEPI

  June 3 2020, Oslo, Norway; Seoul, South Korea; Telangana, India—CEPI, the Coalition for Epidemic Preparedness Innovations, in collaboration with Ind-CEPI, has announced a new partnering agreement with a consortium comprising Bharat Biotech (BBIL) and the International Vaccine Institute (IVI) to advance the development of […]
06/04/2020

IVI partners with Seoul National University Hospital to start Phase 1/2 clinical trial of INOVIO’s COVID-19 DNA (INO-4800) vaccine in South Korea

First COVID-19 vaccine clinical study approved in South Korea funded by CEPI through INOVIO, and supported by KCDC/KNIH 2-stage trial to test INOVIO’s COVID-19 vaccine (INO-4800) using well-established DNA platform technology in adults     June 4, 2020, SEOUL, Korea and PLYMOUTH MEETING, PA, USA […]
06/05/2020

IVI’s statement on environmental sustainability

Climate change is a global health issue, exacerbating environmental degradation, food shortage, water contamination, migration of disease-bearing mosquito vectors, and forced displacement of populations, among other precarious conditions with serious health implications. Vaccination, reinforced by other public health measures such as Water, Sanitation, and Hygiene […]
06/06/2020

Asian Boss | World’s Leading Vaccine Expert Fact-Checks COVID-19 Vaccine Conspiracy